These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 8189233)

  • 1. 5-Hydroxytryptamine2 and beta-adrenergic receptor regulation in rat brain following chronic treatment with desipramine and fluoxetine alone and in combination.
    Goodnough DB; Baker GB
    J Neurochem; 1994 Jun; 62(6):2262-8. PubMed ID: 8189233
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of desipramine and iprindole on levels of enantiomers of fluoxetine in rat brain and urine.
    Aspeslet LJ; Baker GB; Coutts RT; Torok-Both GA
    Chirality; 1994; 6(2):86-90. PubMed ID: 8204417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reevaluation of the regulation of beta-adrenergic receptor binding by desipramine treatment.
    Riva MA; Creese I
    Mol Pharmacol; 1989 Jul; 36(1):211-8. PubMed ID: 2546051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Desipramine administration in the olfactory bulbectomized rat: changes in brain beta-adrenoceptor and 5-HT2A binding sites and their relationship to behaviour.
    Mudunkotuwa NT; Horton RW
    Br J Pharmacol; 1996 Apr; 117(7):1481-6. PubMed ID: 8730743
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein kinase C in rat brain cortex and hippocampus: effect of repeated administration of fluoxetine and desipramine.
    Mann CD; Vu TB; Hrdina PD
    Br J Pharmacol; 1995 Jun; 115(4):595-600. PubMed ID: 7582477
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adrenergic and serotonergic receptor binding in rat brain after chronic desmethylimipramine treatment.
    Bergstrom DA; Kellar KJ
    J Pharmacol Exp Ther; 1979 May; 209(2):256-61. PubMed ID: 220405
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of age on the rate of recovery of beta-adrenergic receptors in rat brain following desmethylimipramine-induced subsensitivity.
    Greenberg LH; Brunswick DJ; Weiss B
    Brain Res; 1985 Feb; 328(1):81-8. PubMed ID: 2982468
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tryptophan-depletion challenge in depressed patients treated with desipramine or fluoxetine: implications for the role of serotonin in the mechanism of antidepressant action.
    Delgado PL; Miller HL; Salomon RM; Licinio J; Krystal JH; Moreno FA; Heninger GR; Charney DS
    Biol Psychiatry; 1999 Jul; 46(2):212-20. PubMed ID: 10418696
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapid down regulation of beta-adrenoceptors by co-administration of desipramine and fluoxetine.
    Baron BM; Ogden AM; Siegel BW; Stegeman J; Ursillo RC; Dudley MW
    Eur J Pharmacol; 1988 Sep; 154(2):125-34. PubMed ID: 2465908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between electrocortical activity and beta-adrenergic receptor function in the rat after chronic desimipramine treatment.
    Krijzer FN; Schipper J; Tulp MT; Koopman PA
    J Neural Transm Gen Sect; 1989; 78(1):73-87. PubMed ID: 2547025
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of concurrent subchronic treatments with desmethylimipramine and propranolol on beta-adrenergic and serotonin2 receptors in rat brain.
    Mason GA; Walker CH; Little KY
    Psychopharmacology (Berl); 1993; 110(1-2):110-4. PubMed ID: 7870868
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic fluoxetine or desmethylimipramine treatment alters 5-HT2 receptor mediated c-fos gene expression.
    Tilakaratne N; Yang Z; Friedman E
    Eur J Pharmacol; 1995 Aug; 290(3):263-6. PubMed ID: 7589222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Desipramine-induced down regulation of beta-adrenergic receptors: effects of noradrenergic and serotonergic neuronal activities and of alpha 2-adrenergic receptor mediated mechanisms].
    Matsubara S
    Hokkaido Igaku Zasshi; 1987 Mar; 62(2):301-10. PubMed ID: 3038720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Down-regulation of rat beta-adrenoceptors by clenbuterol or desipramine does not require chronic treatment: [3H] CGP-12177 binding reveals rapid (24 hour) modulation.
    Newman-Tancredi A; Verrièle L; Chaput C; Millan MJ
    Brain Res Bull; 1996; 41(2):93-6. PubMed ID: 8879672
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The significance of beta-adrenoceptor down regulation in the desipramine action in the forced swimming test.
    Kitada Y; Miyauchi T; Kosasa T; Satoh S
    Naunyn Schmiedebergs Arch Pharmacol; 1986 May; 333(1):31-5. PubMed ID: 2874504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential effects of the tricyclic antidepressant desipramine on the density of adrenergic receptors in juvenile and adult rats.
    Deupree JD; Reed AL; Bylund DB
    J Pharmacol Exp Ther; 2007 May; 321(2):770-6. PubMed ID: 17293562
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of thyroid state on beta-adrenergic and serotonergic receptors in rat brain.
    Mason GA; Bondy SC; Nemeroff CB; Walker CH; Prange AJ
    Psychoneuroendocrinology; 1987; 12(4):261-70. PubMed ID: 2821568
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Receptor alterations associated with serotonergic agents: an autoradiographic analysis.
    Wamsley JK; Byerley WF; McCabe RT; McConnell EJ; Dawson TM; Grosser BI
    J Clin Psychiatry; 1987 Mar; 48 Suppl():19-25. PubMed ID: 3029045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simultaneous quantification of fluoxetine, norfluoxetine, and desipramine using gas chromatography with nitrogen-phosphorus detection.
    Goodnough DB; Baker GB; Coutts RT
    J Pharmacol Toxicol Methods; 1995 Nov; 34(3):143-7. PubMed ID: 8573764
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term treatment with the antidepressants fluoxetine and desipramine potentiates endocrine responses to the serotonin agonists 6-chloro-2-[1-piperazinyl]-pyrazine (MK-212) and (+-)-1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane HCl (DOI).
    Li Q; Brownfield MS; Battaglia G; Cabrera TM; Levy AD; Rittenhouse PA; van de Kar LD
    J Pharmacol Exp Ther; 1993 Aug; 266(2):836-44. PubMed ID: 8394920
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.